Navamedic

Navamedic ASA: Invitation to 2025 2nd quarter presentation

Oslo, August 11, 2025 - Navamedic ASA (OSE: Nava) will be presenting its 2nd

quarter/1st half 2025 results on Thursday, August 14, 2025. The presentation

will be held at Haakon VIIs gate 2 in Oslo and the event will start at 08.30

CET. A link to the webcast and the presentation will be available through the

Navamedic web site on the following link:

https://navamedic.com/investors/financial-results/

For further information, please contact:

Kathrine Gamborg Andreassen, CEO, +47 951 78 680 E-mail: [email protected]

Lars Hjarrand, CFO, +47 917 62 842 E-mail: [email protected]

About Navamedic

Navamedic ASA is a Nordic pharmaceutical company dedicated to enhancing people's

quality of life by being a reliable supplier of high-quality prescription,

consumer health, and hospital products to hospitals and pharmacies. Our growing

product portfolio has been carefully selected to meet current public health

concerns, such as obesity, Parkinson's disease, and gastro-related ailments, to

empower people to live healthier and more fulfilling lives. What sets us apart

is our deep-rooted commitment to understanding the needs and requirements of the

countries where we are present. Our local insight and competence enable us to

understand the specific needs of each country where we operate and ultimately to

gain market access. This makes us a preferred partner for international

companies expanding their footprint across the Nordics and Benelux regions,

through either in-licensing or out-licensing. Navamedic has been listed on the

Oslo Stock Exchange since 2006 (ticker: NAVA) and is headquartered in Oslo,

Norway. For more information, please visit www.Navamedic.com

AI Terminal